KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Re: Maria De Santis, Joan Palou Redorta, Hiroyuki Nishiyama, et al. Durvalumab in Combination with BCG for BCG-naive, High-risk, Non-muscle-invasive Bladder Cancer (POTOMAC): Final Analysis of a Randomised, Open-label, Phase 3 trial. Lancet 2025;406:2221-34.

Renate Pichler, José Daniel Subiela, Félix Guerrero-Ramos

Eur Urol 89(6) e147-e148

PMID41644375
PMCID-
DOI10.1016/j.eururo.2026.01.028
发表日期2026-02-05
摘要

摘要

无摘要

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。